Concomitant i.v. and oral clodronate in the relief of bone pain--a double-blind placebo-controlled study in patients with prostate cancer - Wikidata - wikimedia - TriplyDB

Concomitant i.v. and oral clodronate in the relief of bone pain--a double-blind placebo-controlled study in patients with prostate cancer

Concomitant i.v. and oral clodronate in the relief of bone pain--a double-blind placebo-controlled study in patients with prostate cancer

http://www.wikidata.org/entity/Q36431182

about

Chemotherapy for hormone-refractory prostate cancer Bisphosphonates for advanced prostate cancer Molecular Mechanisms of Bone Metastasis: Which Targets Came from the Bench to the Bedside?Bisphosphonates for the relief of pain secondary to bone metastases.Malignant bone pain: pathophysiology and treatments.Using bisphosphonates to control the pain of bone metastases: evidence-based guidelines for palliative care.Zoledronate for metastatic bone disease and pain: a meta-analysis of randomized clinical trials.The new bisphosphonate, Zometa (zoledronic acid), decreases skeletal complications in both osteolytic and osteoblastic lesions: a comparison to pamidronate.The potential role of bisphosphonates in prostate cancer.The management of hormone-relapsed prostate cancer.Bisphosphonate therapy in the oncology setting.Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy: recommendations for diagnosis and therapies.Advances in the use of bisphosphonates in the prostate cancer setting.Biphosphonates in advanced prostate and renal cell cancer--current status and potential applications.The role of bisphosphonates in the management of prostate cancer.Zoledronic acid in the management of metastatic bone disease.Assessing pharmacological interventions for bone metastases: the need for more patient-centered outcomes.Evidence on the analgesic role of bisphosphonates and denosumab in the treatment of pain due to bone metastases: A systematic review within the European Association for Palliative Care guidelines project.Skeletal complications in cancer patients with bone metastases.Use of bisphosphonates for the treatment of metastatic bone pain. A survey of palliative physicians in the UK.Radiological changes following second-line zoledronic acid treatment in breast cancer patients with bone metastases.The use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkers.Bisphosphonates for advanced prostate cancer.Management of the side effects of androgen deprivation therapy in men with prostate cancer

P2860

Q24243797-694938CF-4534-462A-9DC8-25FAEE590E10 Q24244161-532DE030-CD79-42A6-A24D-40AFF8BFAD1C Q28068956-14604767-E0FA-45B4-B62A-4CE9C7B046A7 Q32139406-2E3351F6-545B-4214-BF71-11F0A599C760 Q34040552-0C371C08-F866-4B04-870F-7041AD84985D Q34162842-DEDBEF8E-5C68-4FCC-9136-42433A3103F1 Q34320376-95A7F417-3EFF-4C86-9AF1-7C122533E97F Q35004491-3D1FA59D-34BE-4116-B9A9-F4EA1E44956F Q35081743-E9757FD2-B70D-4F21-BFDA-36A176239123 Q35583205-DB44977B-DA18-4A2A-8999-A25DDEE85E81 Q35602668-55B6A4E1-8D87-403C-B357-1F1A380C6812 Q35675197-25C1C23F-FDBC-4A98-88CA-C488E21911FC Q35679766-AE6EF1E1-7780-438C-BA4F-3470EA13B37E Q36403183-5D1F48A1-C94E-46C5-8C65-E6C67AB0A187 Q36450794-67E8E8C9-4628-4754-B095-4A6E9838D7E5 Q36708315-B77E524D-64D0-43CE-9740-A227517023C8 Q38018675-C67B3182-C809-401C-8A94-073E1932DD8C Q38785899-C6593BDC-0A86-48CD-9B64-D38311F09C2C Q38917438-ECB004C6-6EA1-40FB-9682-F2F8CE481F6A Q43574694-44276C2A-6029-42CC-9B02-C63CF120E501 Q46098015-2C076EFC-EDAF-4E62-BAF0-80D8220ECB18 Q46832072-65C06BB9-FA2A-4A74-B783-F2D942FACBC4 Q47248454-E262B05D-E047-4C59-85D5-97F02DFA652E Q57143367-99A282E2-1624-4E83-B783-BEEC64071A3D

P2860

Concomitant i.v. and oral clodronate in the relief of bone pain--a double-blind placebo-controlled study in patients with prostate cancer

http://www.wikidata.org/entity/Q36431182

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年学术文章

@wuu

1997年学术文章

@zh-cn

1997年学术文章

@zh-hans

1997年学术文章

@zh-my

1997年学术文章

@zh-sg

1997年學術文章

@yue

1997年學術文章

@zh

1997年學術文章

@zh-hant

name

Concomitant i.v. and oral clod ...... patients with prostate cancer

@ast

Concomitant i.v. and oral clod ...... patients with prostate cancer

@en

type

label

Concomitant i.v. and oral clod ...... patients with prostate cancer

@ast

Concomitant i.v. and oral clod ...... patients with prostate cancer

@en

prefLabel

Concomitant i.v. and oral clod ...... patients with prostate cancer

@ast

Concomitant i.v. and oral clod ...... patients with prostate cancer

@en

P1433

Q36431182-DC988E91-0274-41E0-B703-A5CD95A465A1

P1476

Q36431182-1C55FC6F-BD2D-4E55-A2E7-0FF23AC8A304

P2093

Q36431182-25A5C591-581B-4C89-AD77-D6A7D7DC6F92

Q36431182-6521DE64-C695-4A18-9335-A7E950A8990A

Q36431182-8D0BC997-806E-48CF-8C72-0B7961C62352

Q36431182-B0913B4B-F34A-4F00-AC5E-15DA418A4159

Q36431182-C8D775E1-719B-48F0-BE0F-30A2CFBB0D1C

Q36431182-D3A8BAB9-661B-4620-862F-F195BE919B19

P2860

Q36431182-01CE9865-4DCE-4D63-A354-99A29D24A062

Q36431182-0E929AFC-5B9E-495F-92AF-58990EF56F4B

Q36431182-1BA70A74-8FE2-4605-94B0-8848BB73A0EA

Q36431182-37F1B5E0-5F9E-4E97-8FFE-7E24FA910330

Q36431182-53E0D2FA-0514-4518-B635-CBD77E0934A8

Q36431182-581797BD-5EAE-4842-83ED-4554B9277FCB

Q36431182-813F0E81-67F7-4ECA-9521-62CD71C8A45A

Q36431182-97A89D1B-E557-4A3A-8A93-91964608331E

Q36431182-AEEF32F5-77A0-45B8-89B3-1FC43249ADB9

Q36431182-D80AEF56-8608-4157-9296-510F41981C2D

P2888

Q36431182-C564B866-8976-4489-A452-9158456C3E71

P304

Q36431182-D156CA63-7C0F-4372-916E-9DF95AAD4926

P31

Q36431182-FB5BBE81-DEBD-4276-9C0B-C2F2A5398A96

P356

Q36431182-221ACD62-C720-4AEA-A5AC-B8FBF8FBD38E

P407

Q36431182-5FE19917-0971-4011-9B97-A1DBE526E9B5

P433

Q36431182-B0016A40-99A8-48A1-9BAD-DE813276B9E3

P478

Q36431182-55860498-7913-41C3-A2EE-B2CBB02031F5

P577

Q36431182-83A3D06C-2CEE-4FFE-94D4-6B48AA053729

P5875

Q36431182-B15FAC37-9A58-4C66-9852-D7468E4C64D0

P6179

Q36431182-1E7CD6CD-A0A3-4B34-995B-47563CD59664

P698

Q36431182-21E86E37-999F-4BDF-827E-28EB0D7248B6

P921

Q36431182-C1064535-CE01-4504-9B06-5AA5C9A2FAD7

P932

Q36431182-2CBE7B30-876D-48CB-A249-A077464154E9

P356

P1433

British Journal of Cancer

P1476

Concomitant i.v. and oral clod ...... patients with prostate cancer

@en

P2093

Elomaa I

http://www.w3.org/2001/XMLSchema#string

Kylmälä T

http://www.w3.org/2001/XMLSchema#string

Risteli J

http://www.w3.org/2001/XMLSchema#string

Risteli L

http://www.w3.org/2001/XMLSchema#string

Tammela TL

http://www.w3.org/2001/XMLSchema#string

Taube T

http://www.w3.org/2001/XMLSchema#string

P2860

Clodronate therapy of metastatic bone disease in patients with prostatic carcinoma

Pain relief and quality-of-life assessment following intravenous and oral clodronate in hormone-escaped metastatic prostate cancer.

The effect of clodronate on bone in metastatic prostate cancer. Histomorphometric report of a double-blind randomised placebo-controlled study.

The effect of combined intravenous and oral clodronate treatment on bone pain in patients with metastatic prostate cancer.

Evaluation of the effect of oral clodronate on skeletal metastases with type 1 collagen metabolites. A controlled trial of the Finnish Prostate Cancer Group.

Effect of oral clodronate on bone pain. A controlled study in patients with metastic prostatic cancer.

Dichloromethylene-diphosphonate in patients with prostatic carcinoma metastatic to the skeleton.

Chemotherapy of advanced prostatic cancer. Evaluation of response parameters.

Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan.

Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen.

P2888

P304

939-942

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.1997.488

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

76

http://www.w3.org/2001/XMLSchema#string

P577

1997-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13898824

http://www.w3.org/2001/XMLSchema#string

P6179

1038764387

http://www.w3.org/2001/XMLSchema#string

P698

9328156

http://www.w3.org/2001/XMLSchema#string

P921

P932

2228066

http://www.w3.org/2001/XMLSchema#string